Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HUC-MSCs with Injectable Collagen Scaffold in POF
NCT02644447Phase 2Completed
- Sponsor
- Chinese Academy of Sciences
- Start
- Oct 2015
- Primary completion
- Oct 2018
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord derived mesenchymal stem cells in primary ovarian insufficiency (POI), sponsored by Chinese Academy of Sciences. Started Oct 2015; status: completed.
02
Drugs
human umbilical cord derived mesenchymal stem cells
03
Conditions
primary ovarian insufficiency (POI)
Beyond the preview
Go deeper on NCT02644447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02644447.